Literature DB >> 28677560

BRAF-MEK inhibition in melanoma brain metastases: a new hope.

Peter A Forsyth1, Keiran S M Smalley2, Vernon K Sondak3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28677560     DOI： 10.1016/S1470-2045(17)30449-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and brain metastases: The implications for BRAF inhibitor therapy.

Authors:  Enda J Hannan; Donal P O'Leary; Stephen P MacNally; Elaine W Kay; Michael A Farrell; Patrick G Morris; Colm P Power; Arnold D K Hill
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.